Indian Pharma Cos To Grow By 7-9% In FY24, Domestic Expansion On Cards

The credit rating agency ICRA expects the revenues of the sample set of 25 Indian pharmaceutical companies (which account for 60 per cent of the overall Indian pharmaceutical industry) to grow by 7-9 per cent in FY2024, post a YoY growth of 10 per cent in FY2023, the rating agency said in a statement

GSK Settles First Zantac Cancer Lawsuit Due For US Trial

The case, brought by California resident James Goetz in Alameda County Superior Court, was to go to trial on July 24 and would have been the first test of how Zantac cancer claims fared before a jury.

Changing Landscape Of Indian Pharma Market

Despite continued price erosion in the US and Europe pharma markets, most companies have reported sequential improvement in margins, supported by some stabilisation of raw material costs and steady performance in other key markets. However, companies are also taking active cost optimisation measures, including discontinuation of low margin products and rationalisation of R&D spends with an increasing focus on complex molecules and specialty products

Centre Revokes Licenses Of 18 Pharma Companies For Manufacturing Spurious Drugs: Report

The government of India has canceled the licenses of 18 pharma companies for manufacturing of spurious medicines following an inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 States

Indian Pharma To Grow By 6-8% In FY24, Aided By Price Hikes In NLEMs: ICRA

The agency stated that the IPM witnessed a YoY growth of 7.7 per cent in 9M FY2023 supported by a price growth of 6.8 per cent and growth of 2.3 per cent from new product introductions, while volumes declined by 1.2 per cent. ICRA predicts that price increases will remain the primary growth driver for IPM in the near term

Domestic Pharma Industry Revenues Projected To Grow 6-8% In FY23: ICRA

The revenues of homegrown drug firms are expected to moderate from a growth of 8-10 per cent in 2021-22, it stated citing findings from the sample set of sample set of 21 companies

Hyperscale & Edge Data Centres Are The Future

With data being touted as the new oil, it is estimated that data centres will consume more than three percent of the global electrical energy consumption, which is massive

Pharma Industry To Be Given Priority To Come Back To Operation Post Taukate: Goyal

The minister also directed the railway authorities to closely monitor the situation, and be ready to rush the essential items to the affected areas in the shortest possible time, and provide help in any manner.

GSK To Launch Late-Stage Testing Of Syncytial Virus Vaccine

RSV vaccine development has been fraught with setbacks for decades but the pharma industry is gearing up to bring a first inoculation to market over the next few years.

62 People Have Same Wealth As 3.5 Billion

In China, the rich 1% own a third of its wealth, while the poorest 25% own 1%, according to a recent study conducted by Peking University’s Institute of Social Sciences.

Mindset Malady